Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221962 · ClinicalTrials.gov registry record · Phase 4
Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00221962 is a Phase 4 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT00221962, a Phase 4 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
To look at the cognitive effects of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder. To examine the safety, effectiveness and tolerability of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221962
The ClinicalTrials.gov registry entry for NCT00221962 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00221962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221962 about?
NCT00221962 is a clinical study titled "Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)". To look at the cognitive effects of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder. To examine the safety, effectiveness and tolerability of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder.
What is the current status of trial NCT00221962?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2005-04. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00221962?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00221962?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.